Literature DB >> 25110069

Frequency of angina pectoris and secondary events in patients with stable coronary heart disease (from the Heart and Soul Study).

Alexis L Beatty1, John A Spertus2, Mary A Whooley3.   

Abstract

The extent to which angina pectoris (AP) predicts secondary cardiovascular events beyond independent of measures of disease severity is unknown. We evaluated the association between AP frequency and secondary events in patients with stable coronary heart disease (CHD). We administered the Seattle Angina Questionnaire to 1,023 participants with stable CHD enrolled from September 2000 to December 2002 and followed for a median of 8.9 years. We used Cox proportional hazards to evaluate the association of AP frequency with death and subsequent hospitalization for AP, revascularization, myocardial infarction (MI), or heart failure. At enrollment, 633 (62%) participants reported no AP, 279 (27%) reported monthly AP, and 111 (11%) reported daily or weekly AP. During follow-up, 396 participants died, 204 were hospitalized for AP, 194 for revascularization, 140 for MI, and 188 for heart failure. Compared with participants without AP, participants with daily or weekly AP were more likely to be hospitalized for AP (hazard ratio [HR] 3.3; 95% confidence interval [CI] 2.3 to 4.7; p<0.001), revascularization (HR 2.0; 95% CI 1.3 to 2.9; p=0.001), or heart failure (HR 1.6; 95% CI 1.0 to 2.5; p=0.03) and more likely to die (HR 1.5; 95% CI 1.1 to 2.0; p=0.01). AP was not independently associated with MI (HR 1.3; 95% CI 0.8 to 2.3; p=0.29). After adjusting for demographics, co-morbidities, treadmill exercise capacity, ejection fraction, and inducible ischemia, frequency of AP remained independently associated with hospitalization for AP (HR 2.4; 95% CI 1.6 to 3.6; p<0.001), revascularization (HR 1.7; 95% CI 1.1 to 2.7; p=0.02), and death (HR 1.4; 95% CI 1.0 to 2.0; p=0.045). In conclusion, in outpatients with stable CHD, AP frequency predicts higher rates of secondary cardiovascular events and death, independent of objective measures of disease severity.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25110069      PMCID: PMC4163066          DOI: 10.1016/j.amjcard.2014.07.009

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute.

Authors:  Russell V Luepker; Fred S Apple; Robert H Christenson; Richard S Crow; Stephen P Fortmann; David Goff; Robert J Goldberg; Mary M Hand; Allan S Jaffe; Desmond G Julian; Daniel Levy; Teri Manolio; Shanthi Mendis; George Mensah; Andrzej Pajak; Ronald J Prineas; K Srinath Reddy; Veronique L Roger; Wayne D Rosamond; Eyal Shahar; A Richey Sharrett; Paul Sorlie; Hugh Tunstall-Pedoe
Journal:  Circulation       Date:  2003-11-10       Impact factor: 29.690

2.  Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association.

Authors:  John S Rumsfeld; Karen P Alexander; David C Goff; Michelle M Graham; P Michael Ho; Frederick A Masoudi; Debra K Moser; Véronique L Roger; Mark S Slaughter; Kim G Smolderen; John A Spertus; Mark D Sullivan; Diane Treat-Jacobson; Julie J Zerwic
Journal:  Circulation       Date:  2013-05-06       Impact factor: 29.690

3.  Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease.

Authors:  R M Califf; D B Mark; F E Harrell; M A Hlatky; K L Lee; R A Rosati; D B Pryor
Journal:  J Am Coll Cardiol       Date:  1988-01       Impact factor: 24.094

Review 4.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

6.  History of depression, angina, and quality of life after acute coronary syndromes.

Authors:  John S Rumsfeld; David J Magid; Mary E Plomondon; Anne E Sales; Gary K Grunwald; Nathan R Every; John A Spertus
Journal:  Am Heart J       Date:  2003-03       Impact factor: 4.749

7.  Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease.

Authors:  Dariush Mozaffarian; Chris L Bryson; John A Spertus; Mary B McDonell; Stephan D Fihn
Journal:  Am Heart J       Date:  2003-12       Impact factor: 4.749

8.  Depressive symptoms and health-related quality of life: the Heart and Soul Study.

Authors:  Bernice Ruo; John S Rumsfeld; Mark A Hlatky; Haiying Liu; Warren S Browner; Mary A Whooley
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

9.  Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.

Authors:  J A Spertus; J A Winder; T A Dewhurst; R A Deyo; J Prodzinski; M McDonell; S D Fihn
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094

10.  Incidence and prognostic implications of stable angina pectoris among women and men.

Authors:  Harry Hemingway; Alison McCallum; Martin Shipley; Kristiina Manderbacka; Pekka Martikainen; Ilmo Keskimäki
Journal:  JAMA       Date:  2006-03-22       Impact factor: 56.272

View more
  5 in total

1.  A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS.

Authors:  Konstantin Schwarz; Satnam Singh; Satish Kumar Parasuraman; Maggie Bruce; Lee Shepstone; Martin Feelisch; Magdalena Minnion; Shakil Ahmad; John Horowitz; Dana K Dawson; Michael P Frenneaux
Journal:  Future Cardiol       Date:  2016-10-12

2.  Sex-based inequalities in contemporary UK hospital management of stable chest pain.

Authors:  Mirvat Alasnag; Nouf Alanazi
Journal:  Open Heart       Date:  2021-06

3.  Serum Levels of Cystatin C, N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP), and Cardiac Function in Patients with Unstable Angina Pectoris.

Authors:  Manyun Long; Lang Li
Journal:  Med Sci Monit       Date:  2020-03-13

4.  Prevalence of Angina Among Primary Care Patients With Coronary Artery Disease.

Authors:  Daniel M Blumenthal; Sidney E Howard; Jennifer Searl Como; Sandra M O'Keefe; Steven J Atlas; Daniel M Horn; Neil W Wagle; Jason H Wasfy; Robert W Yeh; Joshua P Metlay
Journal:  JAMA Netw Open       Date:  2021-06-01

5.  Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.

Authors:  Alon Eisen; Deepak L Bhatt; P Gabriel Steg; Kim A Eagle; Shinya Goto; Jianping Guo; Sidney C Smith; E Magnus Ohman; Benjamin M Scirica
Journal:  J Am Heart Assoc       Date:  2016-09-28       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.